HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief: Elizabeth Arden, Ronkin Part Ways; Lauder Execs Advance; More

This article was originally published in The Rose Sheet

Executive Summary

LUXE Brands and Fekkai Brands, which the former created through a joint venture earlier this year to acquire the Frederic Fekkai brand from P&G, will be led by Joel Ronkin, who has left Elizabeth Arden after 16 years of service. More people news.

You may also be interested in...



In Brief: Contamination Recall; ‘Made In America’ Questioned; More

Contract manufacturer Sensible Organics recalls Nourish Organic facial skin-care items due to potential contamination; Revlon's "Almay Simply American" marketing comes under fire for alleged deception. More news in brief.

Sliding Scale: Bar For COVID Therapeutics EUAs ‘Can Be Somewhat Variable’ – FDA’s Peter Marks

Marks appeared to use the variable EUA bar to justify what many viewed as early mistakes by FDA during COVID-19, and to emphasize the importance of physician awareness of the strength of evidence used to authorize a drug.

Can US FDA Share Drug Sponsor’s Information With Patent & Trademark Office?

Patent office could request information from FDA that is material to patentability, speakers at USPTO-FDA ‘listening session’ advise the agencies. Information exchange raises questions about trade secret protection and burdens on agencies.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019749

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel